Jin Peng
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
-
- COVID-19 and healthcare impacts
- Cancer survivorship and care
- Global Cancer Incidence and Screening
Papers in
- Oncology 9
- Global Cancer Incidence and Screening 3
- Inflammatory Biomarkers in Disease Prognosis 2
-
- Breast Cancer Treatment Studies 2
- Co-authors
- Wei Yan (3 shared papers)Hui Xu (6 shared papers)Fuxiang Zhou (6 shared papers)Conghua Xie (5 shared papers)Ling Xia (3 shared papers)Alain Dubreuil (2 shared papers)O. Ganry (2 shared papers)Yingying Shi (3 shared papers)
- Journals
- Frontiers in Public Health (2 papers)Microvascular Research (2 papers)Cancer Medicine (2 papers)FEBS Journal (2 papers)Nature Communications (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Jin Peng
37 papers receiving 672 citations
Peers
Comparison fields: 5 of 87
- Cancer Research 105
- Oncology 182
- Pharmacology 35
- Complementary and alternative medicine 30
- Molecular Biology 208
Countries citing papers authored by Jin Peng
This map shows the geographic impact of Jin Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Peng more than expected).
Fields of papers citing papers by Jin Peng
This network shows the impact of papers produced by Jin Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Peng. The network helps show where Jin Peng may publish in the future.
Co-authors
The 25 scholars most cited alongside Jin Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 84 | |
| 2 | 2023 | 75 | |
| 3 | 2018 | 66 | |
| 4 | 2013 | 62 | |
| 5 | 2023 | 56 | |
| 6 | 2004 | 31 | |
| 7 | 2023 | 30 | |
| 8 | 2021 | 28 | |
| 9 | 2009 | 26 | |
| 10 | 2021 | 26 | |
| 11 | 2018 | 25 | |
| 12 | 2012 | 23 | |
| 13 | 2018 | 21 | |
| 14 | 2014 | 18 | |
| 15 | 2023 | 16 | |
| 16 | 2016 | 13 | |
| 17 | 2020 | 11 | |
| 18 | 2018 | 9 | |
| 19 | 2022 | 9 | |
| 20 | 2019 | 8 |
About Jin Peng
Jin Peng is a scholar working on Oncology, Cancer Research, Pharmacology, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine, having authored 45 papers that have together received 685 indexed citations. Recurring topics across this work include Nuclear Receptors and Signaling (4 papers), Macrophage Migration Inhibitory Factor (3 papers), Global Cancer Incidence and Screening (3 papers), Advanced Thermoelectric Materials and Devices (3 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Breast Cancer Treatment Studies (2 papers), Mitochondrial Function and Pathology (2 papers) and Medicinal Plant Pharmacodynamics Research (2 papers). The work is most often cited by research in Cancer Research (105 citations), Oncology (182 citations), Pharmacology (35 citations), Complementary and alternative medicine (30 citations) and Molecular Biology (208 citations). Jin Peng has collaborated with scholars based in China, United States and France. Frequent co-authors include Wei Yan, Hui Xu, Fuxiang Zhou, Conghua Xie, Ling Xia, Alain Dubreuil, O. Ganry, Yingying Shi, Yahua Zhong and Huan-Gang Jiang. Their work appears in journals such as Frontiers in Public Health, Microvascular Research, Cancer Medicine, FEBS Journal and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.